Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... "Venezuelanequineencephalitisvirus (VEEV) is an important human and veterinary pathogen causing ... molecular pathogenesis and may provide insights into effective alphavirus-based vaccine design." Simmons and colleagues published their study in the Journal of ...
2009 JUN 8 ... available vaccines or antiviral drugs capable of protecting against infection with Venezuelanequineencephalitisvirus (VEEV), although an adenovirus vector expressing VEEV ... VEEV structural proteins protects mice from challenge with VEEV and is potentially a vaccine suitable for human use. This work examines whether alpha interferon (IFN-alpha) could ...
2009 MAR 2 ... their study in Viral Immunology (CpG Used as an Adjuvant for an Adenovirus-Based Venezuelan Equine Encephalitis Virus Vaccine Increases the Immune Response to the Vector, But Not to the Transgene Product. Viral ...
2009 JUN 15 ... According to recent research from the United States, "Venezuelanequineencephalitisvirus (VEE) replicon particles (VRP) were used to model the initial ... A. Schafer, University of North Carolina, Dept. of Microbiology & Immunology, Carolina Vaccine Institute, Chapel Hill, NC 27599, USA.
Publisher contact information for ...
2008 APR 28 ... system, immunizations were performed with VEE/SIN-gag replicon particles, composed of Venezuelanequineencephalitisvirus (VEE) replicon RNA and Sindbis surface structure (SIN). ... Vaccines, Viral, Virology, Novartis.
This article was prepared by AIDS Vaccine Week editors from staff and other reports. Copyright 2008, AIDS Vaccine Week via ...
2008 MAY 12 ... IRBO), will provide its adjuvant candidate, Viprovex(R), for nonclinical studies of a Venezuelanequineencephalitisvaccine developed at DynPort Vaccine Company LLC (DVC), a Computer ... Sciences Corporation (NYSE: CSC) company.
Venezuelan equine encephalitis virus (VEEV) is a naturally emerging disease with the potential to be used as a biological ...
2008 JUL 21 ... nonmucosal Ag delivery."
"One such system, footpad delivery of Venezuelanequineencephalitisvirus replicon particles (VRP), led to the local production of IgA ... Thompson, University of North Carolina, Dept. of Microbiology and Immunology, Carolina Vaccine Institute, Chapel Hill, NC 27599 USA..
Publisher contact information for ...
2008 DEC 30 ... and identified recombinant vesicular stomatitis virus (rVSV) and recombinant Venezuelanequineencephalitisvirus replicons (VRP) as the most synergistic regimen," wrote B. ... New research, 'Comparison of multiple vaccine vectors in a single heterologous prime-boost trial,' is the subject of a report. ...
2008 OCT 13 ... "Defective chimeric alphaviral particles derived from the Sindbis and Venezuelanequineencephalitis viruses encoding either the HCV envelope glycoprotein gpE1/gpE2 ... Virology, "Broad, multispecific CD4(+) and CD8(+) T-cell responses to the hepatitis C virus (HCV), as well as virus-cross-neutralizing antibodies, are associated with recovery from ... to antiviral treatment. In order to recapitulate all of these responses in an ideal vaccine regimen, we have explored the use of recombinant HCV polypeptides combined with various ...
2008 SEP 1 ... A (1 study), meningococcal C (1 study), tetanus (1 study), brucella (1 study), Venezuelanequineencephalitis (1 study) and rabies (4 studies), with sex-difference in humoral ... Oxford OX5 1GB, Oxon, England.
Keywords: Australia, Hepatitis A Virus Vaccines, Biotechnology, Central Nervous System Disease, Diphtheria, Encephalitis, Flu, ... diphtheria, yellow fever, Venezuelan equine encephalitis and in some studies with rabies vaccine," wrote I.F Cook and colleagues, University of Newcastle.
The ...
2008 SEP 8 ... ofV3526, a live attenuated vaccine derived from a fulllength infectious clone of Venezuelanequineencephalitisvirus (VEEV) Trinidad donkey strain (TrD), a comparator VEEV vaccine ...
2008 SEP 15 ... expressed antigens in numerous experimental systems. We have recently demonstrated that Venezuelanequineencephalitisvirus replicon particles (VRP) possess adjuvant activity for ... vaccines."
Thompson and colleagues published their study in Vaccine (Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to ...
2008 JUN 23 ... study, 'C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelanequineencephalitisvirus infection,' is now available. According to recent research ... is now available. According to recent research from the United States, "The TC-83 vaccine strain of Venezuelan equine encephalitis virus (VEEV) causes encephalitis and death in ...
2008 NOV 10 ... humoral immune induction," researchers in the United States report.
"Venezuelanequineencephalitisvirus replicon particles (VRP) expressing the hemagglutinin (HA) ... promote immune induction, and specifically mucosal immune induction, with alphavirus vaccine vectors."
Thompson and colleagues published their study in Vaccine (The ...
2008 NOV 10 ... in some vaccinees, we developed chimeric alphavirus vaccine candidates using either Venezuelanequineencephalitis attenuated vaccine strain TC-83, a naturally attenuated strain of ... vaccine candidates for chikungunya,' are discussed in a new report. "Chikungunya virus (CHIKV) is an emerging alphavirus that has caused major epidemics in India and islands ...
